Cigar and pipe-tobacco makers received a reprieve Thursday from a looming deadline for the placement of new, larger health warnings on packages and ads when a federal judge, citing a recent Supreme Court decision, halted the U.S. Food and Drug Administration mandate pending appeal of a May ruling.
BMW of North America LLC has been slapped with a putative class action in New Jersey state court alleging the company failed to disclose a defect in certain M3 vehicles that causes "catastrophic engine failure" and increases the risk of crashes.
Drug companies are directing heavy fire at a bellwether lawsuit for hospitals in multidistrict litigation over the opioid crisis, calling it a “dangerous” case that suggests health care providers can sue any business that harms an uninsured patient.
A group of Texas soda drinkers hit Dr Pepper Snapple Group Inc. with a proposed class action, alleging that its claim of having "real ginger" in its ginger ale is a lie intended to trick consumers into paying extra for drinks they were led to believe were healthier than sodas.
A Texas attorney on Thursday told a Rhode Island federal judge not to accept a special magistrate’s recommendation that a legal malpractice suit — brought by former clients claiming that he misled them into taking a smaller part of a global settlement in surgical mesh litigation — should not be arbitrated.
An oncologist testifying for Johnson & Johnson in a St. Louis trial that sees 22 women allege J&J’s talcum powder gave them cancer on Thursday told the jury that genetic testing and family histories show that several of the plaintiffs had a genetic predisposition to develop cancer.
An Illinois federal judge on Thursday dismissed Baxter International Inc. and Hospira Inc. without prejudice from an Alabama health care provider’s proposed antitrust class action alleging that they conspired to fix the price of intravenous saline solution by using recalls to stage a shortage, agreeing that the theory is "implausible."
A New York state court certified a class of New York residents who claim they’ve been harmed by nearly 60 years of exposure to a toxic chemical that resulted from an industrial process of coating fabrics with Teflon, according to an order on Tuesday.
An Illinois federal judge on Thursday partially certified and slightly trimmed a class action claiming Fiat Chrysler vehicles were outfitted with infotainment systems that were vulnerable to hacking, saying there are enough facts and evidence backing the consumers’ fraud and warranty claims to advance the case.
A West Virginia federal judge on Thursday tossed a products liability suit against Bristol-Myers Squibb and Otsuka Pharmaceutical that alleged the companies’ drug Abilify caused a man to develop a twitching condition, finding that the man’s case ignored that the medication explicitly identified his condition as a potential side effect.
The federal government and the state of Wisconsin have urged the Seventh Circuit to uphold a deal with NCR Corp. and Appvion Inc. to finish cleaning up a Wisconsin Superfund site contaminated with polychlorinated biphenyls by the paper industry activity, despite paper manufacturer P.H. Glatfelter Co.'s objections.
In a pair of cases with implications for thousands of lawsuits pending in Philadelphia against a Johnson & Johnson unit, the Pennsylvania Supreme Court agreed on Thursday to weigh when the clock began to run on claims of abnormal breast growth in adolescent boys prescribed the antipsychotic drug Risperdal.
An Illinois federal judge vacated a $140 million verdict against AbbVie Inc. from the second bellwether in multidistrict litigation over testosterone products on Thursday, saying the jury’s finding for the company on the case’s strict liability claim threw a wrench in the rest of its verdict.
Shell Offshore Inc. agreed to pay nearly $3.9 million in connection with a May 2016 spill of more than 80,000 gallons of oil in the Gulf of Mexico that occurred about 100 miles from the Louisiana coast, according to a consent decree filed Thursday in federal court.
Health authorities in the United Kingdom on Thursday urged pharmacies to yank heart medicines containing valsartan, which are being recalled in Europe after it came to light that they may have been tainted with a carcinogen at a Chinese factory.
A helicopter training and services company has sued a division of Lockheed Martin, claiming in Pennsylvania federal court that a helicopter designed and manufactured by the division was partly responsible for a helicopter crash that killed an instructor and student.
A California federal judge on Tuesday paused a putative class action accusing Nature’s Way Products LLC of misleading consumers about the health of its coconut oil, citing the Ninth Circuit's recent decision to ax a $200 million settlement in multidistrict litigation involving automakers Hyundai and Kia.
What makes a law firm truly global? What does it take to handle the biggest and most complex cross-border matters? These firms know. Here, Law360 reveals its eighth annual ranking of the firms with the most international clout.
Setting up shop across the globe may seem impossible for smaller law firms, but it can be done — and it's not the only way to get business overseas. Here, Law360 looks at what firms should think about when deciding whether, and how, to go global.
With Britain less than a year from exiting the European Union, firms on Law360’s Global 20 have begun pushing deeper into the countries remaining in the bloc, adding offices and industry specialists in a shift that could rebalance how BigLaw works in the region.
The U.S. Food and Drug Administration recently launched an initiative to reduce the use of e-cigarettes and related products by young people. While it is not clear how extensively the FDA will try to restrict electronic nicotine delivery systems and e-liquids, forthcoming proposals may be substantial, say Azim Chowdhury and Benjamin Wolf of Keller & Heckman LLP.
The U.S. Environmental Protection Agency recently held its National Leadership Summit with the goal of “taking action” on the emerging contaminants known as perfluoroalkyl or polyfluoroalkyl substances. In part one of this two-part series, Jeffrey Dintzer and Nathaniel Johnson of Alston & Bird LLP discuss the possible legal consequences for businesses that manufacture, sell or consume PFAS products.
As the Judicial Panel on Multidistrict Litigation heads to Chicago for its May 31 hearing session, Alan Rothman of Arnold & Porter observes the panel’s golden anniversary with a retrospective look at its origins in the enactment of the MDL statute in April 1968, and reviews its most recent hearing session held in Atlanta on March 29.
The growth of litigation funding has only increased the controversy surrounding it. Looking to move beyond the rhetoric for and against the practice, attorney and investment analytics expert J.B. Heaton, of J.B. Heaton PC and Conjecture LLC, attempts an objective analysis of the underlying economics of the litigation funding arrangement.
Courts are acknowledging a shifting consumer preference toward electronic mediums. Proposed changes to Rule 23, scheduled to take effect at the end of this year, will officially provide for the use of electronic notice in class actions — a change that could save parties a significant amount of money, say Brandon Schwartz and Maggie Ivey of Garden City Group LLC.
Today's female lawyers stand on the shoulders of several generations of pioneers. Here, historian Jill Norgren explains how the status of women in the legal profession has changed since the 1870s.
Earlier this month, a California federal court dismissed a claim that Horizon Organic milk, which contained an additive noted on the package, was not truly organic, and thus violated state laws against product misrepresentation. The decision makes clear that if a label identifies a product’s content, a claimant cannot assert that she read the label and then was misled, says Jeff Brown of Thompson Coburn LLP.
As different jurisdictions impose their own disclosure requirements regarding commercial litigation finance, there can be no “one size fits all” approach to ensuring confidentiality. But litigants, lawyers and litigation funders may be able to decrease disclosure risks through a handful of best practices, says Alan Guy of Vannin Capital.
Earlier this month, the Ninth Circuit amended its 2017 decision in Davidson v. Kimberly-Clark Corp., and made it clear that a plaintiff who has learned the truth about an allegedly false advertisement only has standing if she intends to purchase the product again in the future, says Lucia Roibal of Morrison & Foerster LLP.
For the first time, the U.S. Consumer Product Safety Commission has imposed a civil penalty against a company for violations of Poison Prevention Packaging Act standards — despite no evidence of consumer injury. Prudent pharmaceutical and household product manufacturers may want to review their packaging compliance programs and reporting, to avoid penalties, litigation and recalls, say Amy Rubenstein and Jamie Davis of DLA Piper.